MedTrace Logo

Feasibility Study of Transcranial Ultrasound Stimulation on Alzheimer's Disease Patients

NCT03896698 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-04-28

No results posted yet for this study

Summary

Currently, the main treatment method for Alzheimer's disease (AD) is chemotherapy. However, the effectiveness of drugs is moderate and there are several side effects. In this clinical trial, the investigators would like to activate the brain by the transcranial ultrasound stimulation (TUS). This is a feasibility study to evaluate the safety and initial effectiveness of TUS for the treatment of patients with mild AD.

Conditions

  • Alzheimer Disease

Interventions

DEVICE

Transcranial Ultrasound Stimulation

TUS activate the brain cells

Sponsors & Collaborators

  • Taipei Veterans General Hospital, Taiwan

    collaborator OTHER_GOV

  • National Yang Ming Chiao Tung University

    lead OTHER

Principal Investigators

  • Feng-Yi Yang, Ph.D. · National Yang Ming Chiao Tung University

Study Design

Allocation
RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-23
Primary Completion
2021-05-31
Completion
2021-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03896698 on ClinicalTrials.gov